{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:57:16Z","timestamp":1784973436369,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA036553"],"award-info":[{"award-number":["R01DA036553"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA035200"],"award-info":[{"award-number":["T32DA035200"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00213-019-05227-x","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T15:03:01Z","timestamp":1553180581000},"page":"2569-2577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine"],"prefix":"10.1007","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-0160","authenticated-orcid":false,"given":"William W.","family":"Stoops","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph L.","family":"Alcorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon R.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abner O.","family":"Rayapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Lile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"5227_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.drugalcdep.2012.10.026","volume":"130","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Fennell TR, Snyder RW, Negus SS (2013a) Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys. Drug Alcohol Depend 130:158\u2013166","journal-title":"Drug Alcohol Depend"},{"key":"5227_CR2","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1038\/npp.2013.180","volume":"38","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Fennell TR, Snyder RW, Negus SS (2013b) Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys. Neuropsychopharmacology 38:2698\u20132707","journal-title":"Neuropsychopharmacology"},{"key":"5227_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.drugalcdep.2013.05.005","volume":"131","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Negus SS (2013c) Effects of 14-day treatment with the schedule iii anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys. Drug Alcohol Depend 131:204\u2013213","journal-title":"Drug Alcohol Depend"},{"key":"5227_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.addbeh.2012.06.009","volume":"37","author":"LC Bidwell","year":"2012","unstructured":"Bidwell LC, MacKillop J, Murphy JG, Tidey JW, Colby SM (2012) Latent factor structure of a behavioral economic cigarette demand curve in adolescent smokers. Addict Behav 37:1257\u20131263","journal-title":"Addict Behav"},{"key":"5227_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/ADM.0000000000000206","volume":"10","author":"BL Bolin","year":"2016","unstructured":"Bolin BL, Stoops WW, Sites JP, Rush CR (2016) Abuse potential of oral phendimetrazine in cocaine-dependent individuals: implications for agonist-like replacement therapy. J Addict Med 10:156\u2013165","journal-title":"J Addict Med"},{"key":"5227_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00213-013-3312-5","volume":"231","author":"NR Bruner","year":"2014","unstructured":"Bruner NR, Johnson MW (2014) Demand curves for hypothetical cocaine in cocaine-dependent individuals. Psychopharmacology 231:889\u2013897","journal-title":"Psychopharmacology"},{"key":"5227_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1037\/a0027379","volume":"20","author":"S Bujarski","year":"2012","unstructured":"Bujarski S, MacKillop J, Ray LA (2012) Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Exp Clin Psychopharmacol 20:181\u2013190","journal-title":"Exp Clin Psychopharmacol"},{"key":"5227_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.drugalcdep.2017.08.036","volume":"80","author":"AJ Butler","year":"2017","unstructured":"Butler AJ, Rehm J, Fischer B (2017) Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses. Drug Alcohol Depend 80:401\u2013416","journal-title":"Drug Alcohol Depend"},{"key":"5227_CR9","volume-title":"Family Practice Guidelines","author":"JC Cash","year":"2014","unstructured":"Cash JC, Glass CA (2014) Family Practice Guidelines, Third edn. Springer, New York","edition":"Third"},{"key":"5227_CR10","first-page":"777","volume":"242","author":"LD Chait","year":"1987","unstructured":"Chait LD, Uhlenhuth EH, Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242:777\u2013783","journal-title":"J Pharmacol Exp Ther"},{"key":"5227_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","volume":"96","author":"SD Comer","year":"2008","unstructured":"Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL (2008) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96:1\u201315","journal-title":"Drug Alcohol Depend"},{"key":"5227_CR12","first-page":"351","volume":"7","author":"RL Corwin","year":"1987","unstructured":"Corwin RL, Woolverton WL, Schuster CR, Johanson CE (1987) Anorectics: effects on food intake and self-administration in rhesus monkeys. Alcohol Drug Res 7:351\u2013361","journal-title":"Alcohol Drug Res"},{"key":"5227_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuroscience.2016.03.002","volume":"324","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Blough BE, Fennell TR, Snyder RW, Nader MA (2016a) Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys. Neuroscience 324:367\u2013376","journal-title":"Neuroscience"},{"key":"5227_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/pr.115.011668","volume":"68","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Stoops WW, Rush CR (2016b) Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: A review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev 68:533\u2013562","journal-title":"Pharmacol Rev"},{"key":"5227_CR15","first-page":"955","volume":"243","author":"R de la Garza","year":"1987","unstructured":"de la Garza R, Johanson CE (1987) Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. J Pharmacol Exp Ther 243:955\u2013962","journal-title":"J Pharmacol Exp Ther"},{"key":"5227_CR16","first-page":"817","volume":"241","author":"SM Evans","year":"1987","unstructured":"Evans SM, Johanson CE (1987) Amphetamine-like effects of anorectics and related compounds in pigeons. J Pharmacol Exp Ther 241:817\u2013825","journal-title":"J Pharmacol Exp Ther"},{"key":"5227_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2004.02.018","volume":"78","author":"RW Foltin","year":"2004","unstructured":"Foltin RW, Haney M (2004) Intranasal cocaine in humans: Acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78:93\u2013101","journal-title":"Pharmacol Biochem Behav"},{"key":"5227_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pbb.2015.03.023","volume":"134","author":"RW Foltin","year":"2015","unstructured":"Foltin RW, Haney M, Rubin E, Reed SC, Vadhan N, Balter R, Evans SM (2015) Development of translational preclinical models in substance abuse: Effects of cocaine administration on cocaine choice in humans and non-human primates. Pharmacol Biochem Behav 134:12\u201321","journal-title":"Pharmacol Biochem Behav"},{"key":"5227_CR19","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2010.175","volume":"35","author":"MK Greenwald","year":"2010","unstructured":"Greenwald MK, Lundahl LH, Steinmiller CL (2010) Sustained release d-amphetamine reduces cocaine but not \u2018speedball\u2019-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine\/heroin polydrug abusers. Neuropsychopharmacology 35:2624\u20132637","journal-title":"Neuropsychopharmacology"},{"key":"5227_CR20","first-page":"164","volume-title":"Advances in behavioral pharmacology","author":"RR Griffiths","year":"1979","unstructured":"Griffiths RR, Bradford LD, Brady JV (1979) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology, vol 2. Academic Press, New York, pp 164\u2013208"},{"key":"5227_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1369-1600.2008.00121.x","volume":"14","author":"M Haney","year":"2009","unstructured":"Haney M (2009) Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict Biol 14:9\u201321","journal-title":"Addict Biol"},{"key":"5227_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","volume":"199","author":"M Haney","year":"2008","unstructured":"Haney M, Spealman R (2008) Controversies in translation research: drug self-administration. Psychopharmacology 199:403\u2013419","journal-title":"Psychopharmacology"},{"key":"5227_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","volume":"70","author":"O Havakuk","year":"2017","unstructured":"Havakuk O, Rezkalla SH, Kloner RA (2017) The cardiovascular effects of cocaine. J Am Coll Cardiol 70:101\u2013113","journal-title":"J Am Coll Cardiol"},{"key":"5227_CR24","doi-asserted-by":"publisher","first-page":"eaau1184","DOI":"10.1126\/science.aau1184","volume":"361","author":"H Jalal","year":"2018","unstructured":"Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS (2018) Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 361:eaau1184","journal-title":"Science"},{"key":"5227_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1037\/pha0000045","volume":"23","author":"MN Koffarnus","year":"2015","unstructured":"Koffarnus MN, Franck CT, Stein JS, Bickel WK (2015) A modified exponential behavioral economic demand model to better describe consumption data. Exp Clin Psychopharmacol 23:504\u2013512","journal-title":"Exp Clin Psychopharmacol"},{"key":"5227_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00213-008-1367-5","volume":"203","author":"J Mackillop","year":"2009","unstructured":"Mackillop J, Murphy JG, Tidey JW, Kahler CW, Ray LA, Bickel WK (2009) Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology 203:33\u201340","journal-title":"Psychopharmacology"},{"key":"5227_CR27","first-page":"433","volume":"4","author":"D McLeod","year":"1982","unstructured":"McLeod D, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 4:433\u2013436","journal-title":"Behav Res Methods Instrum"},{"key":"5227_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pbb.2015.09.020","volume":"138","author":"SJ Moeller","year":"2015","unstructured":"Moeller SJ, Stoops WW (2015) Cocaine choice procedures in animals, humans and treatment seekers: Can we bridge the divide? Pharmacol Biochem Behav 138:133\u2013141","journal-title":"Pharmacol Biochem Behav"},{"key":"5227_CR29","first-page":"135","volume":"49","author":"OF M\u00fcller","year":"1975","unstructured":"M\u00fcller OF, Hundt HK, Gosling JA (1975) Availability of phendimetrazine from sustained and non-sustained action formulations. S Afr Med J 49:135\u2013139","journal-title":"S Afr Med J"},{"key":"5227_CR30","first-page":"885","volume":"261","author":"AH Oliveto","year":"1992","unstructured":"Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261:885\u2013894","journal-title":"J Pharmacol Exp Ther"},{"key":"5227_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/jat\/26.7.393","volume":"26","author":"KL Preston","year":"2002","unstructured":"Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET (2002) Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol 26:393\u2013400","journal-title":"J Anal Toxicol"},{"key":"5227_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-2999(02)01830-7","volume":"447","author":"RB Rothman","year":"2002","unstructured":"Rothman RB, Katsnelson M, Vu N, Partilla JS, Dersch CM, Blough BE, Baumann MH (2002) Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. Eur J Pharmacol 447:51\u201357","journal-title":"Eur J Pharmacol"},{"key":"5227_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archpsyc.1991.01810250045005","volume":"48","author":"BJ Rounsaville","year":"1991","unstructured":"Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43\u201351","journal-title":"Arch Gen Psychiatry"},{"key":"5227_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4155\/fmc.11.184","volume":"4","author":"CR Rush","year":"2012","unstructured":"Rush CR, Stoops WW (2012) Agonist replacement therapy for cocaine dependence: A Translational review. Future Med Chem 4:245\u2013265","journal-title":"Future Med Chem"},{"key":"5227_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1124\/jpet.102.048439","volume":"306","author":"CR Rush","year":"2003","unstructured":"Rush CR, Stoops WW, Hays LR, Glaser PEA, Hays LS (2003) Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306:195\u2013204","journal-title":"J Pharmacol Exp Ther"},{"key":"5227_CR36","unstructured":"Rush CR, Bolin BL, Rayapati AO, Hays LR, Lile JA (2017) Bupropion-Naltrexone combinations as a pharmacotherapy for cocaine dependence. Presented at the College on Problems of Drug Dependence, Montreal, QC"},{"key":"5227_CR37","unstructured":"Rush CR, Reynolds AR, Stoops WW, Lile JA, Rayapati AO, Hays LR (2018) Topiramate-Phentermine combinations as a pharmacotherapy for cocaine dependence. Presented at the College on Problems of Drug Dependence, San Diego, CA"},{"key":"5227_CR38","first-page":"64","volume":"95","author":"CR Schuster","year":"1989","unstructured":"Schuster CR, Snyder M (1989) NIDA\u2019s medication development program. NIDA Res Monogr 95:64\u201373","journal-title":"NIDA Res Monogr"},{"key":"5227_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7326\/M17-1812","volume":"168","author":"MS Shiels","year":"2018","unstructured":"Shiels MS, Freedman ND, Thomas D, Berrington de Gonzalez A (2018) Trends in US drug overdose deaths in non-Hispanic black, Hispanic, and non-Hispanic white persons, 2000-2015. Ann Intern Med 168:453\u2013455","journal-title":"Ann Intern Med"},{"key":"5227_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","volume":"7","author":"HA Skinner","year":"1982","unstructured":"Skinner HA (1982) The drug abuse screening test. Addict Behav 7:363\u2013371","journal-title":"Addict Behav"},{"key":"5227_CR41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","volume":"64","author":"M Sofuoglu","year":"2013","unstructured":"Sofuoglu M, DeVito EE, Waters AJ, Carroll KM (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64:452\u2013463","journal-title":"Neuropharmacology"},{"key":"5227_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1037\/pha0000020","volume":"23","author":"JS Stein","year":"2015","unstructured":"Stein JS, Koffarnus MN, Snider SE, Quisenberry AJ, Bickel WK (2015) Identification and management of nonsystematic purchase task data: toward best practice. Exp Clin Psychopharmacol 23:377\u2013386","journal-title":"Exp Clin Psychopharmacol"},{"key":"5227_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pnpbp.2011.10.003","volume":"36","author":"WW Stoops","year":"2012","unstructured":"Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR (2012a) Alternative reinforcer response cost impacts cocaine choice in humans. Prog Neuropsychopharm Biol Psychiatry 36:189\u2013193","journal-title":"Prog Neuropsychopharm Biol Psychiatry"},{"key":"5227_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1360-0443.2011.03766.x","volume":"107","author":"WW Stoops","year":"2012","unstructured":"Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR (2012b) Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction 107:1140\u20131147","journal-title":"Addiction"},{"key":"5227_CR45","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00213-016-4260-7","volume":"233","author":"WW Stoops","year":"2016","unstructured":"Stoops WW, Strickland JC, Hays LR, Rayapati AO, Lile JA, Rush CR (2016) Safety and tolerability of intranasal cocaine during phendimetrazine maintenance. Psychopharmacology 233:2055\u20132063","journal-title":"Psychopharmacology"},{"key":"5227_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1037\/pha0000096","volume":"24","author":"JC Strickland","year":"2016","unstructured":"Strickland JC, Lile JA, Rush CR, Stoops WW (2016) Comparing exponential and exponentiated models of drug demand in cocaine users. Exp Clin Psychopharmacol 24:447\u2013455","journal-title":"Exp Clin Psychopharmacol"},{"key":"5227_CR47","unstructured":"Substance Abuse and Mental Health Services Administration (2018) Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from \n                    https:\/\/www.samhsa.gov\/data\/\n                    \n                   on 27 November 2018"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05227-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:19:22Z","timestamp":1589620762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05227-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5227"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05227-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"7 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with all relevant local, national and international ethical standards. All subjects provided sober, written consent prior to participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}